Compare HOMB & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOMB | TXG |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.0B |
| IPO Year | 2006 | 2019 |
| Metric | HOMB | TXG |
|---|---|---|
| Price | $31.04 | $58.55 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 15 |
| Target Price | ★ $31.50 | $20.25 |
| AVG Volume (30 Days) | 1.8M | ★ 3.2M |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | 19.90 | ★ 76.97 |
| EPS | ★ 1.19 | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $10.99 | N/A |
| Revenue Next Year | $5.14 | $7.33 |
| P/E Ratio | $26.06 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $25.50 | $11.17 |
| 52 Week High | $31.70 | $60.69 |
| Indicator | HOMB | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 61.97 | 76.85 |
| Support Level | $27.56 | $17.54 |
| Resistance Level | $31.70 | N/A |
| Average True Range (ATR) | 0.47 | 3.55 |
| MACD | -0.13 | 0.78 |
| Stochastic Oscillator | 61.45 | 98.23 |
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).